Results 251 to 260 of about 368,008 (313)

3D Bioprinted Breast Cancer‐Stroma Model with Tailored Migration‐Permissive Bioink Reveals Impact of Adipose‐Derived Stromal Cells on Cancer Cell Migration and Invasion Dynamics

Advanced Healthcare Materials, EarlyView.
A migration‐permissive bioink composed of methacrylated collagen type I and thiolated hyaluronic acid enables 3D bioprinting of breast cancer‐stroma models. Single‐cell tracking reveals that adipose stromal cells enhance tumor cell motility and stromal invasion, accompanied by collagen remodeling, and a shift in tumor cell morphology.
Sabrina Stecher, Joachim Schenk, Alessandro Cianciosi, Katherina Hemmen, David Böhringer, Franziska Dusi, Jessica Faber, Philipp Stahlhut, Benedikt Gantert, Emilie Rouenhoff, Annika Gmöhling, Tessa Lühmann, Jörg Teßmar, Jürgen Groll, Silvia Budday, Tomasz Jüngst, Ben Fabry, Katrin G. Heinze, Petra Bauer‐Kreisel, Torsten Blunk   +19 more
wiley   +1 more source

Prognostic and Predictive Significance of Claudin-6 Expression in Advanced-Stage High-Grade Serous Ovarian Carcinoma. [PDF]

Diagnostics (Basel)
Demir T, Kefeli M, Aydoğan Demir AR, Uygun FN, Akpunar M, Tekce Yıldız E, Demirağ G.   +6 more
europepmc   +1 more source

Gellan Gum Fluid Gel System for Controlled‐Delivery of Cytokine‐Licensed MSC‐EVs to Enhance Corneal Repair in Limbal Stem Cell Deficiency

Advanced Healthcare Materials, EarlyView.
Gellan gum fluid gel (FG) enables controlled ocular delivery of mesenchymal stromal cell (MSC)‐derived extracellular vesicles (EV). Its shear‐thinning, solid‐liquid‐solid rheology ensures prolonged ocular retention. Sustained MSC‐EV release (∼18% in 6 hrs) supports effective EV ocular delivery.
Seyedmohammad Moosavizadeh, Ava Dashti, Thomas E. Robinson, Robyn Gaffey, Richard Moakes, Neil Lagali, Liam Grover, Thomas Ritter   +7 more
wiley   +1 more source

Genomic Predictors of Platinum Resistance and Survival in High-Grade Serous Ovarian Carcinoma: Insights from an Explorative Targeted Next-Generation Sequencing Analysis. [PDF]

Cancers (Basel)
De Marco C, Rocca V, Migliozzi S, Veneziano C, Gualtieri F, Cerantonio A, Butt TA, Santamaria G, De Angelis MT, Di Cello A, Venturella R, Zullo F, Viglietto G.   +12 more
europepmc   +1 more source

Chemoresistance in gynecologic cancers: mechanistic insights and emerging platforms to overcome drug failure. [PDF]

J Ovarian Res
Garg P, Salgia R, Singhal SS.
europepmc   +1 more source

Correction: Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors. [PDF]

Front Immunol
Alsaafeen BH, Ali BR, Elkord E.
europepmc   +1 more source

Development of Machine-Learned Interatomic Potentials to Predict Structure, Transport, and Reactivity in Platinum-Based Fuel Cells. [PDF]

ACS Omega
Fazel K, Brown S, Clary J, Bose P, Karimitari N, Frischknecht AL, Sundararaman R, Vigil-Fowler D.   +7 more
europepmc   +1 more source

Uncoupling tumor immunogenicity from cell death with platinum(IV)-antibody conjugates. [PDF]

Natl Sci Rev
Liu LY, Yu W, Liu Y, Yang Y, Wei Q, Zhao Z, Yang R, Li JP, Guo Z.   +8 more
europepmc   +1 more source